|
| 37587869 | Diagnostic Accuracy Study of the Pediatric-Specific Ultrasound Scoring System for the Knee Joint in Children With Juvenile Idiopathic Arthritis. | Arthritis Care Res (Hoboken) | 2024 |
| 34363343 | Development and Validation of a Juvenile Spondyloarthritis Disease Flare Measure: Ascertaining Flare in Patients With Inactive Disease. | Arthritis Care and Research | 2023 |
| 35961761 | Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial. | Annals of the Rheumatic Diseases | 2023 |
| 36710243 | Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III Study. | | 2023 |
| 37453737 | Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials. | | 2023 |
| 36755328 | Biologic Abatement and Capturing Kids' Outcomes and Flare Frequency in Juvenile Spondyloarthritis (BACK-OFF JSpA): study protocol for a randomized pragmatic trial. | Trials | 2023 |
| 37067688 | Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design. | Arthritis Rheumatol | 2023 |
| 37004166 | Paediatric rheumatologists do not score the physician's global assessment of juvenile idiopathic arthritis disease activity in the same way. | | 2023 |
| 37308458 | Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic Arthritis. | | 2023 |
| 37425218 | Panuveitis and optic neuropathy following SARS-COV-2 in the absence of multisystem inflammatory syndrome in a child. | | 2023 |
| 37221146 | Long-Term Maintenance of Clinical Responses by Individual Patients With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Abatacept. | | 2023 |
| 35087087 | Juvenile idiopathic arthritis. | Nature Reviews Disease Primers | 2022 |
| 35569465 | Tofacitinib for juvenile idiopathic arthritis - Authors' reply. | Lancet, The | 2022 |
| 35863492 | Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis. | Am J Ophthalmol | 2022 |
| 33278336 | Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis. | Arthritis Care Res (Hoboken) | 2022 |
| 35233993 | 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. | Arthritis and Rheumatology | 2022 |
| 35233989 | 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. | Arthritis Care and Research | 2022 |
| 35233986 | 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis. | Arthritis Care and Research | 2022 |
| 35233961 | 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging. | Arthritis and Rheumatology | 2022 |
| 35105705 | Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference. | Journal of Rheumatology | 2022 |
| 34469569 | Comparative effectiveness and persistence of TNFi and non-TNFi in juvenile idiopathic arthritis: a large paediatric rheumatology centre in the USA. | Rheumatology | 2021 |
| 34176004 | The value of the patient global health assessment in polyarticular juvenile idiopathic arthritis: a nested cohort study. | Journal of Patient-Reported Outcomes | 2021 |
| 33731444 | Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis. | RMD Open | 2021 |
| 33452173 | Absence of Association Between Abatacept Exposure and Initial Infection in Patients With Juvenile Idiopathic Arthritis. | Journal of Rheumatology | 2021 |
| 33506875 | Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis. | Rheumatology | 2021 |
| 32702212 | Functional Ability and Health-Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis. | Arthritis Care and Research | 2021 |
| 33242376 | Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes. | Arthritis Care and Research | 2021 |
| 32951358 | Efficacy and Safety of Tocilizumab for Polyarticular-Course Juvenile Idiopathic Arthritis in the Open-Label Two-Year Extension of a Phase III Trial. | Arthritis and Rheumatology | 2021 |
| 33331127 | Evolution in the Understanding of Pediatric-Onset Axial Spondyloarthritis. | Arthritis Care and Research | 2021 |
| 31421019 | Safety and Effectiveness of Adalimumab in Patients With Polyarticular Course of Juvenile Idiopathic Arthritis: STRIVE Registry Seven-Year Interim Results. | Arthritis Care and Research | 2020 |
| 31948488 | The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis. | Pediatric Rheumatology | 2020 |
| 32396520 | Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis. | RMD Open | 2020 |
| 32648697 | Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open-Label, Active-Treatment Extension Study. | Arthritis and Rheumatology | 2020 |
| 32699034 | Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial. | Annals of the Rheumatic Diseases | 2020 |
| 33029724 | Abatacept: A Review of the Treatment of Polyarticular-Course Juvenile Idiopathic Arthritis. | Paediatric Drugs | 2020 |
| 32524767 | New Medications Are Needed for Children With Juvenile Idiopathic Arthritis. | Arthritis Rheumatol | 2020 |
| 32665432 | Long-term outcomes in patients with polyarticular juvenile idiopathic arthritis receiving adalimumab with or without methotrexate. | RMD Open | 2020 |
| 32503658 | Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study. | Pediatric Rheumatology | 2020 |
| 32660497 | Assessment and treatment of Down syndrome-associated arthritis: a survey of pediatric rheumatologists. | Pediatric Rheumatology | 2020 |
| 30770499 | Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop. | Journal of Rheumatology | 2019 |
| 31783768 | Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis. | Pediatr Rheumatol Online J | 2019 |
| 30547384 | Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary Hospitals. | Paediatric Drugs | 2019 |
| 30335681 | Long-term outcomes of adolescents with juvenile-onset fibromyalgia into adulthood and impact of depressive symptoms on functioning over time. | Pain | 2019 |
| 30232192 | Clinical trials in children and adolescents with systemic lupus erythematosus: methodological aspects, regulatory landscape and future opportunities. | Annals of the Rheumatic Diseases | 2019 |
| 30275259 | Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. | J Rheumatol | 2019 |
| 30225949 | Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinu | Arthritis and Rheumatology | 2019 |
| 30819662 | Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. | | 2019 |
| 31540934 | Immunome perturbation is present in patients with juvenile idiopathic arthritis who are in remission and will relapse upon anti-TNFα withdrawal. | Annals of the Rheumatic Diseases | 2019 |
| 31271789 | Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition. | J Allergy Clin Immunol | 2019 |
| 31021540 | 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. | Arthritis Care Res (Hoboken) | 2019 |